Good clinical practice does not mean endless and mindless tasks that no one knows why they exist aside from generating work and money for CROs – Amer Zeidan
If I am in charge of regulating trials i would cut down 50% of needless bureaucratic red tape without compromising Safety or compliance. Good clinical practice does not mean endless & mindless tasks that no one knows why they exist aside from generating work & money for CROs.
Source: Amer Zeidan / Twitter
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023